New GE Healthcare Instrument Follows Industry Trend to Make Confocal Imaging More Accessible | GenomeWeb

SAN FRANCISCO — GE Healthcare has launched a new version of the IN Cell Analyzer 1000 and will discontinue the current version of the instrument as the company falls in line with an emerging trend to make confocal or confocal-like imaging technology more accessible to certain researchers in pharma and academia, GE officials said at the Cambridge Healthtech Institute High-Content Analysis meeting held here last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.